Products & Services · Gross product sales
Net product sales — Gross product sales
Moderna Net product sales — Gross product sales decreased by 66.8% to $350M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 233.3%, from $105M to $350M. Over 3 years (FY 2021 to FY 2025), Net product sales — Gross product sales shows a downward trend with a -42.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityVolatile
First reportedQ1 2021
Last reportedQ1 2026May 1, 2026
How to read this metric
An increase suggests higher gross demand or higher list pricing, though it must be reconciled with net sales to assess true profitability.
Detailed definition
This represents the total invoiced sales of products before any deductions for rebates, chargebacks, discounts, or retur...
Peer comparison
Standard gross-to-net accounting metric used across the pharmaceutical industry.
Metric ID:
mrna_segment_net_product_sales_gross_product_salesHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.42B | $4.42B | $4.42B | $3.12B | $4.86B | $1.83B | $293M | $2.42B | $3.66B | $222M | $191M | $2.96B | $1.14B | $105M | $176M | $1.97B | $1.05B | $350M |
| QoQ Change | — | +0.0% | +0.0% | -29.4% | +55.7% | -62.4% | -84.0% | +725.9% | +51.3% | -93.9% | -14.0% | >999% | -61.5% | -90.8% | +67.6% | >999% | -46.6% | -66.8% |
| YoY Change | — | — | — | -29.4% | +10.0% | — | — | -22.4% | -24.6% | -87.9% | -34.8% | +22.5% | -68.9% | -52.7% | -7.9% | -33.5% | -7.6% | +233.3% |
Range$105M – $4.86B
CAGR-44.9%
Avg YoY Growth-8.0%
Median YoY Growth-24.6%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Moderna's net product sales — gross product sales?
- Moderna (MRNA) reported net product sales — gross product sales of $350M in Q1 2026.
- How has Moderna's net product sales — gross product sales changed year-over-year?
- Moderna's net product sales — gross product sales increased by 233.3% year-over-year, from $105M to $350M.
- What is the long-term trend for Moderna's net product sales — gross product sales?
- Over 3 years (2021 to 2025), Moderna's net product sales — gross product sales has grown at a -42.8% compound annual growth rate (CAGR), from $17.68B to $3.31B.
- What does net product sales — gross product sales mean?
- Total sales revenue before subtracting discounts, rebates, and returns.